Moreover, a recent study demonstrated that obese patients with prostate cancer have an increased expression of CXCL1 and its overexpression is linked to obesity-dependent tumor adipose stromal cells’ recruitment and, ultimately, promotes the progression of prostate cancer [43]. This evidence concerns the gene CXCL1 and obesity due to melanocortin 4 receptor deficiency.